These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15870092)

  • 41. Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.
    Kiefer F; Witt SH; Frank J; Richter A; Treutlein J; Lemenager T; Nöthen MM; Cichon S; Batra A; Berner M; Wodarz N; Zimmermann US; Spanagel R; Wiedemann K; Smolka MN; Heinz A; Rietschel M; Mann K
    Pharmacogenomics J; 2011 Oct; 11(5):368-74. PubMed ID: 20585342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medications for treating alcohol dependence.
    Williams SH
    Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.
    Colagiuri B; Morley K; Boakes R; Haber P
    Psychother Psychosom; 2009; 78(3):167-71. PubMed ID: 19270472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.
    Han DH; Lyool IK; Sung YH; Lee SH; Renshaw PF
    Drug Alcohol Depend; 2008 Mar; 93(3):279-83. PubMed ID: 17983709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy.
    Perney P; Lehert P; Mason BJ
    Alcohol Alcohol; 2012; 47(2):133-9. PubMed ID: 22218671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
    Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
    Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acamprosate for alcohol dependence?
    Drug Ther Bull; 1997 Sep; 35(9):70-2. PubMed ID: 9350085
    [No Abstract]   [Full Text] [Related]  

  • 49. Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients.
    Annemans L; Vanoverbeke N; Tecco J; D'Hooghe D
    Eur Addict Res; 2000 Jun; 6(2):71-8. PubMed ID: 10899732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
    McKay JR; Lynch KG; Shepard DS; Pettinati HM
    Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gambling on acamprosate: a case report.
    Raj YP
    J Clin Psychiatry; 2010 Sep; 71(9):1245-6. PubMed ID: 20923626
    [No Abstract]   [Full Text] [Related]  

  • 52. Acamprosate and primitive reflexes.
    Guzik P; Bankes L; Brown TM
    Ann Pharmacother; 2007 Apr; 41(4):715-8. PubMed ID: 17389668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers.
    Schmidt LG; Smolka MN
    Alcohol Alcohol; 2007; 42(3):241-6. PubMed ID: 17526634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome.
    Krampe H; Stawicki S; Wagner T; Bartels C; Aust C; Rüther E; Poser W; Ehrenreich H
    Alcohol Clin Exp Res; 2006 Jan; 30(1):86-95. PubMed ID: 16433735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2002 Oct; 36(5):622-8. PubMed ID: 12225445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.
    Tempesta E; Janiri L; Bignamini A; Chabac S; Potgieter A
    Alcohol Alcohol; 2000; 35(2):202-9. PubMed ID: 10787398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
    Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW
    Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A critical review of pharmacoeconomic studies of acamprosate.
    Poldrugo F; Haeger DA; Comte S; Walburg J; Palmer AJ
    Alcohol Alcohol; 2005; 40(5):422-30. PubMed ID: 15939706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Marked reduction of heavy drinking did not reduce nicotine use over 1 year in a clinical sample of alcohol-dependent patients.
    Specka M; Lieb B; Kuhlmann T; Frommann N; Wobrock T; Schifano F; Gaebel W; Scherbaum N
    Pharmacopsychiatry; 2011 May; 44(3):120-1. PubMed ID: 21298613
    [No Abstract]   [Full Text] [Related]  

  • 60. The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate.
    Palmer AJ; Neeser K; Weiss C; Brandt A; Comte S; Fox M
    Alcohol Alcohol; 2000; 35(5):478-92. PubMed ID: 11022023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.